The EMA assessment of avapritinib in the treatment of gastrointestinal stromal tumours harbouring the PDGFRA D842V mutation.
ESMO Open
; 6(3): 100159, 2021 06.
Article
in En
| MEDLINE
| ID: mdl-34023541
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Gastrointestinal Stromal Tumors
Limits:
Adult
/
Humans
Language:
En
Journal:
ESMO Open
Year:
2021
Document type:
Article
Affiliation country:
Países Bajos